The High Court has ruled that Nersa may not deduct a R69-billion cash injection from Eskom's allowable revenue. The High Court has ruled that Nersa may not deduct a R69-billion cash injection from Eskom's allowable revenue. This means the power utility can apply for higher tariffs. The court ordered that the average standard Eskom tariffs approved by…
Eskom has pulled out of several violent parts of Khayelitsha. The driver managed to escape to safety.An Eskom minivan burst into flames in an arson attack.Now Eskom has pulled the plug on electricity repairs in numerous parts of Khayelitsha - until it is safe.Eskom has pulled out of several violent parts of Khayelitsha – after…
Eskom says it managed to bring back the generating units that tripped and is replenishing emergency reserves for the coming week. Photo: Beeld Power utility Eskom has asked the public to reduce electricity usages after a number of generations units tripped, leading to a constrained power supply. "This morning one generation unit each at the Kendal…
Power lines feed electricity to the national grid from Koeberg Nuclear Power Station. (Photo by: Education Images/UIG via Getty Images) The Integrated National Electrification Programme grant has been cut by R1.5 billion.The move is expected to affect electricity connection to some 40 000 households. Over 8 million households have been connected to national grid through the INEP between…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.